New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2013
10:13 EDTKO, AA, STJ, MCRS, CHK, CIT, HUN, PBR, RRGB, LM, EMC, ABG, PPS, PAY, MSFT, HTZ, CSX, CBOE, AIGOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AIG (AIG) downgraded to Market Perform from Outperform at Wells Fargo... CBOE Holdings (CBOE) downgraded to Market Perform from Outperform at Raymond James... CIT Group (CIT) downgraded to Neutral from Buy at Janney Capital... CSX (CSX) downgraded to Neutral from Buy at Goldman... Chesapeake (CHK) downgraded to Neutral from Buy at SunTrust... EMC (EMC) downgraded to Equal Weight from Overweight at Morgan Stanley... Hertz Global (HTZ) downgraded to Underweight from Overweight at Morgan Stanley... Legg Mason (LM) downgraded to Market Perform from Outperform at Keefe Bruyette... MICROS (MCRS) downgraded to Outperform from Top Pick at RBC Capital... Microsoft (MSFT) downgraded to Equal Weight from Overweight at Morgan Stanley... Red Robin (RRGB) downgraded to Neutral from Buy at BofA/Merrill... St. Jude Medical (STJ) downgraded to Market Perform from Outperform at BMO Capital... VeriFone (PAY) downgraded to Sector Perform from Outperform at RBC Capital... Petrobras (PBR) downgraded to Neutral from Outperform at Macquarie... Alcoa (AA) downgraded to Underperform from Neutral at Macquarie... Post Properties (PPS) downgraded to Underweight from Hold at KeyBanc... Huntsman (HUN) downgraded to Neutral from Buy at UBS... Coca-Cola (KO) downgraded to Hold from Buy at Argus... Asbury Automotive (ABG) downgraded to Neutral from Buy at Buckingham.
News For AIG;CBOE;CIT;CSX;EMC;CHK;HTZ;LM;MCRS;MSFT;RRGB;STJ;PAY;PBR;AA;PPS;HUN;KO;ABG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
March 17, 2015
09:13 EDTCHKChesapeake downgraded to Sell from Neutral at Global Hunter
09:13 EDTMSFTMSFT announced several partnerships with industry leaders
At Microsoft Convergence 2015, Microsoft (MSFT) announced several new partnerships with industry leaders. Teaming up with Microsoft, Ford Motor (F) will expand connected services for customers around the world with the creation of the Ford Service Delivery Network. Microsoft also announced several partnerships and collaboration agreements with leading companies in sales, field service, digital transaction management and analytics markets. Microsoft and InsideSales.com will offer its complete sales acceleration platform. Microsoft and FieldOne Systems announced their agreement to bring the FieldOne Sky field service management solution into the Microsoft Dynamics global independent software vendor program. DocuSign and Microsoft announced that the two companies will bring DocuSign's Digital Transaction Management platform to Microsoft Dynamics CRM users. Microsoft also announced the acquisition of intellectual property from Fusion Software which will add Voice of the Customer capabilities to Microsoft Dynamics.
09:07 EDTMSFTDISH's Sling TV launches on Xbox One
Subscribe for More Information
09:05 EDTMSFTMicrosoft exec confirms plans to drop IE brand for new browser, The Verge says
Subscribe for More Information
09:05 EDTMSFTMicrosoft Band now available at Best Buy, Target, Amazon, Re/code reports
Subscribe for More Information
09:03 EDTMSFTElectronic Arts, Visceral Games announce availability of Battlefield Hardline
Subscribe for More Information
07:12 EDTMSFTDeutsche Messe to hold a conference
CeBIT 2015 is being held in Hannover, Germany on March 15-20.
07:08 EDTAAAlcoa weakness creates buying opportunity, says Stifel
Subscribe for More Information
06:07 EDTPPSPost Properties initiated with a Neutral at RW Baird
Subscribe for More Information
March 16, 2015
16:19 EDTRRGBRed Robin appoints Lee Dolan as Chief Marketing Officer
Subscribe for More Information
16:17 EDTRRGBRed Robin promotes Denny Marie Post to Chief Concept Officer
Red Robin Gourmet Burgers announced the promotion of Denny Marie Post to executive vice president and Chief Concept Officer. Post joined Red Robin in August 2011 as senior vice president and Chief Marketing Officer.
16:00 EDTAAOptions Update; March 16, 2015
Subscribe for More Information
13:16 EDTSTJAnalysts upbeat on results of Edwards' Sapien 3 data
The shares of Edwards Lifesciences (EW) are rising after the company released data on its Sapien 3 transcathter aortic valve over the weekend. In notes to investors today, a number of analysts were upbeat on the data. BACKGROUND: Edwards yesterday announced that high- and intermediate-risk patients treated with Sapien 3 demonstrated lower mortality rates than patients treated with previous transcathter aortic valves, or TAVR, made by the company. The patients also had excellent clinical outcomes in the other primary endpoints of stroke and paravalvular regurgitation, the company stated. Meanwhile, a five year study of patients treated with the first generation SAPIEN device showed that the patients had equivalent outcomes to traditional open-heart surgery, and no structural valve deterioration requiring intervention, the company stated. ANALYST REACTION: Edwards' Sapien 3 data was impressive, as the device showed one of the lowest stroke and mortality rates of any major TAVR study so far, Bernstein analyst Derrick Sung wrote in a note to investors earlier today. Data presented by Edwards and other companies at the American College of Cardiology, or ACC, conference this weekend caused investors and the medical community to become more optimistic about the potential for TAVR devices to replace surgical valves, Sung stated. The analyst wrote that he continues to believe that investors are underestimating the potential size of the TAVR market. Also upbeat on Edwards' data was Wells Fargo, which wrote that the data exceeded high expectations and could pressure the FDA to approve Sapien 3 for intermediate risk patients earlier than Edwards' guidance of late 2016. WHAT'S NOTABLE: Analysts were also upbeat on data reported by other companies at the ACC conference. Medtronic's (MDT) data suggested that its CoreValve Evolut-R product may be as effective as Edwards' Sapien 3, Bernstein's Sung stated. The FDA appears to have allowed Boston Scientific's (BSX) left atrial appendage closure, Watchman, to be provided to more patients than expected, research firm Stifel believes. Meanwhile, St. Jude's (STJ) CardioMEMS device yielded "impressive" mortality data, the firm added. Stifel kept Buy ratings on both Medtronic and St. Jude. PRICE ACTION: In early afternoon trading, Edwards Lifesciences climbed 9% to $147.64, Boston Scientific advanced 4% to $17.27, St. Jude added 2% to $67.55, and Medtronic rose 1.3% to $77.50.
10:14 EDTPAYOptions with decreasing implied volatility
Options with decreasing implied volatility: EXPR ULTA SGMS QIHU BKS PAY URBN AGN AGNC
09:03 EDTMSFTMicrosoft price target lowered to $49 from $52 at UBS
UBS lowered its price target on Microsoft to $49 from $52 citing lower PC demand and foreign exchange headwinds. UBS reiterated its Buy rating on Microsoft shares.
08:44 EDTABGAsbury Automotive announces plan to increase technician workforce
Asbury Automotive announced an initiative to hire between 200 and 400 technicians over the next twelve to twenty-four months to meet potential growth opportunities in our parts and service business. Asbury Automotive intends to pursue these candidates through working partnerships with local technical schools, community colleges, vehicle manufacturer partners and the Asbury Technical Institute.
08:26 EDTAIGAIG to acquire controlling stake in NSM Insurance
Subscribe for More Information
08:25 EDTAIGAIG acquires controlling interest in NSM Insurance Group
Subscribe for More Information
08:05 EDTSTJSt. Jude Medical data 'impressive,' says BMO Capital
Subscribe for More Information
07:32 EDTMSFTUBM Tech to hold a conference
Enterprise Connect 2015 is being held in Orlando, Florida on March 16-19.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use